Cardiac transplantation for AL amyloidosis.
作者信息
Hall R, Hawkins P N
机构信息
University of Wales.
出版信息
BMJ. 1994 Oct 29;309(6962):1135-7. doi: 10.1136/bmj.309.6962.1135.
Abstract
摘要
相似文献
1
Cardiac transplantation for AL amyloidosis.心脏移植治疗AL型淀粉样变性
BMJ. 1994 Oct 29;309(6962):1135-7. doi: 10.1136/bmj.309.6962.1135.
2
Heart transplantation in cardiac amyloidosis.心脏淀粉样变性中的心脏移植
Heart Fail Rev. 2017 May;22(3):317-327. doi: 10.1007/s10741-017-9601-z.
3
Cardiac Amyloidosis Presenting as Severe Mitral Regurgitation.
JACC Cardiovasc Imaging. 2016 Aug;9(8):1003-6. doi: 10.1016/j.jcmg.2016.03.011. Epub 2016 Jun 22.
4
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival.
Am J Cardiol. 1995 Oct 1;76(10):739-41. doi: 10.1016/s0002-9149(99)80214-8.
5
Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.系统性（AL）淀粉样变性患者的心脏移植：对8例法国患者的回顾性研究。
Arch Cardiovasc Dis. 2008 Sep;101(9):523-32. doi: 10.1016/j.acvd.2008.06.018. Epub 2008 Nov 17.
6
Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.接受心脏移植的心脏淀粉样变性患者的结局。
JACC Heart Fail. 2020 Jun;8(6):461-468. doi: 10.1016/j.jchf.2019.12.013. Epub 2020 May 6.
7
Placing heart failure and diastolic dysfunction in the case of cardiac amyloid into perspective: what an amyloid heart really looks like.从心脏淀粉样变性病例的角度看待心力衰竭和舒张功能障碍：淀粉样变性心脏的真实面貌。
Int J Cardiovasc Imaging. 2018 Apr;34(4):543-544. doi: 10.1007/s10554-017-1257-1. Epub 2017 Oct 26.
8
Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis.原位心脏移植促进了轻链淀粉样变性患者的自体造血干细胞移植。
Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):17-8. doi: 10.14797/mdcj-8-3-17.
9
Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.家族性转甲状腺素蛋白（TTR）V122I 心脏淀粉样变性的心脏移植。
Amyloid. 2014 Jun;21(2):120-3. doi: 10.3109/13506129.2013.853660. Epub 2014 Feb 6.
10
Pulmonary amyloidosis occurring after heart transplantation for amyloid heart disease.
J Heart Lung Transplant. 1995 Mar-Apr;14(2):402-3.
引用本文的文献
1
High profile transvalvular microaxial flow pump as a bridge to heart transplantation for amyloid cardiomyopathy: A case series.高-profile经瓣膜微轴流泵作为淀粉样心肌病心脏移植的桥梁：病例系列
JHLT Open. 2025 Jul 9;10:100340. doi: 10.1016/j.jhlto.2025.100340. eCollection 2025 Nov.
2
Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment.当前心脏淀粉样变性治疗的疗法和未来展望。
Curr Heart Fail Rep. 2024 Aug;21(4):305-321. doi: 10.1007/s11897-024-00669-7. Epub 2024 May 29.
3
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience.转甲状腺素蛋白淀粉样变心肌病的心脏移植：来自三级中心三十年经验的结果
Front Cardiovasc Med. 2023 Jan 19;9:1075806. doi: 10.3389/fcvm.2022.1075806. eCollection 2022.
4
Heart transplantation in cardiac amyloidosis.心脏淀粉样变性中的心脏移植
Heart Fail Rev. 2017 May;22(3):317-327. doi: 10.1007/s10741-017-9601-z.
5
Amyloid in the cardiovascular system: a review.心血管系统中的淀粉样蛋白：综述
J Clin Pathol. 2005 Feb;58(2):125-33. doi: 10.1136/jcp.2004.017293.
6
Amyloidosis.淀粉样变性
Postgrad Med J. 2001 Nov;77(913):686-93. doi: 10.1136/pmj.77.913.686.
7
Long term results of heart transplantation in patients with amyloid heart disease.淀粉样心脏病患者心脏移植的长期结果。
Heart. 2001 Feb;85(2):202-7. doi: 10.1136/heart.85.2.202.
8
Restrictive Cardiomyopathy.限制性心肌病
Curr Treat Options Cardiovasc Med. 2000 Oct;2(5):431-438. doi: 10.1007/s11936-000-0038-6.
9
Cardiac Amyloidosis.心脏淀粉样变性
Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):209-218. doi: 10.1007/s11936-999-0037-1.
10
Diagnosis and treatment of amyloidosis.淀粉样变性的诊断与治疗。
Ann Rheum Dis. 1997 Nov;56(11):631-3. doi: 10.1136/ard.56.11.631.
本文引用的文献
1
Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.血清淀粉样蛋白P成分闪烁扫描术及周转率研究用于幼年型类风湿关节炎中AA淀粉样变性的诊断和定量监测
Arthritis Rheum. 1993 Jun;36(6):842-51. doi: 10.1002/art.1780360616.
2
3
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性患者肝移植后的临床改善及淀粉样蛋白消退
Lancet. 1993 May 1;341(8853):1113-6. doi: 10.1016/0140-6736(93)93127-m.
4
Amyloidosis (AL). Clinical and laboratory features in 229 cases.淀粉样变性（AL型）。229例患者的临床及实验室特征。
Mayo Clin Proc. 1983 Oct;58(10):665-83.
5
Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.系统性淀粉样变性的超声心动图表现：心脏受累的范围及其与生存率的关系
J Am Coll Cardiol. 1985 Oct;6(4):737-43. doi: 10.1016/s0735-1097(85)80475-7.
6
Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.
Arthritis Rheum. 1986 May;29(5):683-7. doi: 10.1002/art.1780290515.
7
Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.淀粉样蛋白的诊断性放射性核素成像：循环中的人血清淀粉样蛋白P成分的生物靶向作用
Lancet. 1988 Jun 25;1(8600):1413-8. doi: 10.1016/s0140-6736(88)92235-0.
8
Primary systemic amyloidosis--a diagnostic primer.原发性系统性淀粉样变性——诊断入门
Mayo Clin Proc. 1989 Dec;64(12):1505-19. doi: 10.1016/s0025-6196(12)65706-1.
9
Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.用¹²³I标记的血清淀粉样蛋白P成分闪烁扫描法评估系统性淀粉样变性。
N Engl J Med. 1990 Aug 23;323(8):508-13. doi: 10.1056/NEJM199008233230803.
10
Response rates and survival in primary systemic amyloidosis.原发性系统性淀粉样变性的缓解率与生存率
Blood. 1991 Jan 15;77(2):257-62.
Zotero 插件